Circulating NET levels were increased while the plasma DNase I activity was impaired, resulting in the failure to degrade the aberrant NETs in patients with anti-MDA5 autoantibodies, especially in those with ILD. The gene discussed is IFIH1; the disease is interstitial lung disease.